Great Lakes Advisors, LLC Heron Therapeutics, Inc. Transaction History

Great Lakes Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.3 - $6.29 $35,374 - $96,740	-15,380 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$8.35 - $12.6 $6.49 Million - $9.8 Million	-777,776 Reduced 98.06%	15,380 $140,000
Q3 2021 Nov 09, 2021	BUY	$10.13 - $15.0 $710,903 - $1.05 Million	70,178 Added 9.71%	793,156 $8.48 Million
Q2 2021 Aug 11, 2021	BUY	$13.27 - $18.48 $9.59 Million - $13.4 Million	722,978 New	722,978 $11.2 Million
Q1 2020 May 08, 2020	SELL	$10.23 - $24.56 $2.65 Million - $6.37 Million	-259,247 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$17.42 - $26.61 $18,221 - $27,834	1,046 Added 0.41%	259,247 $6.09 Million
Q3 2019 Nov 06, 2019	BUY	$16.36 - $21.39 $4.22 Million - $5.52 Million	258,201 New	258,201 $4.78 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.